| Year |
Citation |
Score |
| 2024 |
Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, ... ... Moysich KB, et al. Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 38530242 DOI: 10.1158/1055-9965.EPI-23-1444 |
0.319 |
|
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Moysich KB, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.365 |
|
| 2023 |
Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, et al. A framework for assessing interactions for risk stratification models: the example of ovarian cancer. Journal of the National Cancer Institute. PMID 37436712 DOI: 10.1093/jnci/djad137 |
0.367 |
|
| 2023 |
Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, et al. Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. Jama Network Open. 6: e230666. PMID 36826816 DOI: 10.1001/jamanetworkopen.2023.0666 |
0.411 |
|
| 2023 |
Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, ... ... Moysich KB, et al. Risk prediction models for endometrial cancer: development and validation in an international consortium. Journal of the National Cancer Institute. PMID 36688725 DOI: 10.1093/jnci/djad014 |
0.324 |
|
| 2023 |
Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, ... ... Moysich KB, et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. Journal of the National Cancer Institute. PMID 36688720 DOI: 10.1093/jnci/djad011 |
0.382 |
|
| 2023 |
Davis EW, McCann SE, Joseph JM, Yeary KHK, Fountzilas C, Moysich KB. Sugar Sweetened and Artificially Sweetened Beverage Consumption and Pancreatic Cancer: A Retrospective Study. Nutrients. 15. PMID 36678146 DOI: 10.3390/nu15020275 |
0.331 |
|
| 2022 |
DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, ... ... Moysich KB, et al. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute. PMID 36210504 DOI: 10.1093/jnci/djac160 |
0.359 |
|
| 2022 |
Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, et al. Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertility and Sterility. PMID 36182623 DOI: 10.1016/j.fertnstert.2022.07.019 |
0.386 |
|
| 2022 |
Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, et al. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101900. PMID 35867953 DOI: 10.1200/JCO.21.01900 |
0.43 |
|
| 2022 |
Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, ... ... Moysich K, et al. Whole-Genome Sequencing Identifies as a Putative Modifier of Cancer Risk in Mutation Carriers. Cancers. 14. PMID 35625955 DOI: 10.3390/cancers14102350 |
0.353 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Moysich KB, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y |
0.323 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Moysich KB, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.385 |
|
| 2021 |
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, ... ... Moysich KB, et al. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789471 DOI: 10.1158/1055-9965.EPI-21-0977 |
0.381 |
|
| 2021 |
Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, Glubb DM, Tyrer JP, Armasu SM, Ong JS, Gharahkhani P, Lu Y, Gao B, Patch AM, ... ... Moysich K, et al. Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34162658 DOI: 10.1158/1055-9965.EPI-20-1817 |
0.354 |
|
| 2021 |
Morrison MEW, Hobika EG, Joseph JM, Stenzel AE, Mongiovi JM, Tang L, McCann SE, Marshall J, Fountzilas C, Moysich KB. Cruciferous vegetable consumption and pancreatic cancer: A case-control study. Cancer Epidemiology. 72: 101924. PMID 33714902 DOI: 10.1016/j.canep.2021.101924 |
0.352 |
|
| 2021 |
Mongiovi JM, Freudenheim JL, Moysich KB, McCann SE. Glycemic Index, Glycemic Load, and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cohort. The Journal of Nutrition. PMID 33693724 DOI: 10.1093/jn/nxab011 |
0.38 |
|
| 2021 |
Phung MT, Lee AW, Wu AH, Berchuck A, Cho KR, Cramer DW, Doherty JA, Goodman MT, Hanley GE, Harris HR, McLean K, Modugno F, Moysich KB, Mukherjee B, Schildkraut JM, et al. Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33619020 DOI: 10.1158/1055-9965.EPI-20-1355 |
0.441 |
|
| 2021 |
Fu Z, Kelley JL, Odunsi K, Edwards RP, Moysich K, Modugno F. Gestational weight gain and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. PMID 33616777 DOI: 10.1007/s10552-021-01405-5 |
0.383 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... Moysich KB, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.414 |
|
| 2020 |
Modugno F, Fu Z, Jordan SJ, Group A, Chang-Claude J, Fortner RT, Goodman MT, Moysich KB, Schildkraut JM, Berchuck A, Bandera EV, Qin B, Sutphen R, McLaughlin JR, Menon U, et al. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies. European Journal of Epidemiology. PMID 32959149 DOI: 10.1007/S10654-020-00682-9 |
0.463 |
|
| 2020 |
Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, ... ... Moysich KB, et al. Circulating CD14 HLA-DR monocytic cells as a biomarker for epithelial ovarian cancer progression. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13343. PMID 32905653 DOI: 10.1111/Aji.13343 |
0.396 |
|
| 2020 |
Stenzel AE, Schlecht NF, Moysich KB. Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data. Journal of Gastrointestinal Cancer. PMID 32803517 DOI: 10.1007/S12029-020-00472-2 |
0.402 |
|
| 2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, ... Moysich K, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.5 |
|
| 2020 |
Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, ... ... Moysich K, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecologic Oncology. PMID 32641237 DOI: 10.1016/J.Ygyno.2020.06.481 |
0.398 |
|
| 2020 |
Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, Simard J, Hall P, Michailidou K, Dennis J, Schmidt MK, Chang-Claude J, Gharahkhani P, Whiteman D, Campbell PT, ... Moysich KB, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nature Communications. 11: 3353. PMID 32620889 DOI: 10.1038/S41467-020-16483-3 |
0.506 |
|
| 2020 |
Martins FC, Couturier DL, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Gentry-Maharaj A, Vrvilo A, Hein A, Talhouk A, Osorio A, Hartkopf AD, Brooks-Wilson A, DeFazio A, ... Moysich KB, et al. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. British Journal of Cancer. PMID 32555365 DOI: 10.1038/S41416-020-0900-0 |
0.446 |
|
| 2020 |
Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... Moysich K, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739 |
0.442 |
|
| 2020 |
Pratapwar M, Stenzel AE, Joseph JM, Fountzilas C, Etter JL, Mongiovi JM, Cannioto R, Moysich KB. Physical Inactivity and Pancreatic Cancer Mortality. Journal of Gastrointestinal Cancer. PMID 32524304 DOI: 10.1007/S12029-020-00441-9 |
0.364 |
|
| 2020 |
Velazquez-Kronen R, Gilbert ES, Linet MS, Moysich KB, Freudenheim JL, Wactawski-Wende J, Simon SL, Cahoon EK, Alexander BH, Doody MM, Kitahara CM. Lung cancer mortality associated with protracted low-dose occupational radiation exposures and smoking behaviors in U.S. radiologic technologists, 1983-2012. International Journal of Cancer. PMID 32506420 DOI: 10.1002/Ijc.33141 |
0.335 |
|
| 2020 |
Fried J, Etter JL, Stenzel AE, Joseph JM, Cannioto R, Danziger IR, Moysich KB. Physical inactivity and head and neck cancer mortality. Head & Neck. PMID 32478442 DOI: 10.1002/Hed.26283 |
0.362 |
|
| 2020 |
Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, Harris HR, Rossing MA, Doherty JA, Fortner RT, Chang-Claude J, Goodman MT, Thompson PJ, Moysich KB, Ness RB, et al. Association Between Breastfeeding and Ovarian Cancer Risk. Jama Oncology. e200421. PMID 32239218 DOI: 10.1001/Jamaoncol.2020.0421 |
0.499 |
|
| 2020 |
Khan ANH, Emmons TR, Wong JT, Alqassim E, Singel KL, Mark J, Smith BE, Tario JD, Eng KH, Moysich KB, Odunsi K, Abrams SI, Segal BH. Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils. Cancer Immunology Research. PMID 32238380 DOI: 10.1158/2326-6066.Cir-19-0556 |
0.371 |
|
| 2020 |
Phung MT, Webb PM, Doherty JA, Harris HR, Thompson PJ, Goodman MT, Moysich K, Modugno F, Ness RB, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Titus L, Lee AW, et al. Abstract B38: Use of progestin-only injectable contraceptive is associated with reduced risk of ovarian cancer in the Ovarian Cancer Association Consortium Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B38 |
0.533 |
|
| 2019 |
Fu Z, Moysich K, Ness RB, Modugno F. Gender of offspring and risk of ovarian cancer: The HOPE study. Cancer Epidemiology. 64: 101646. PMID 31835157 DOI: 10.1016/J.Canep.2019.101646 |
0.509 |
|
| 2019 |
Stenzel AE, Moysich KB. A response to: Vitamin D status may help explain survival disparities among racial/ethnic groups of women with ovarian cancer. Cancer Epidemiology. 101650. PMID 31810884 DOI: 10.1016/J.Canep.2019.101650 |
0.362 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Moysich KB, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8 |
0.352 |
|
| 2019 |
Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, ... ... Moysich K, et al. Identification of novel epithelial ovarian cancer loci in Women of African Ancestry. International Journal of Cancer. PMID 31469419 DOI: 10.1002/Ijc.32653 |
0.304 |
|
| 2019 |
Stenzel AE, Buas MF, Moysich KB. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry. Cancer Epidemiology. 62: 101580. PMID 31400533 DOI: 10.1016/J.Canep.2019.101580 |
0.414 |
|
| 2019 |
Stenzel AE, Abrams SI, Moysich KB. A Call for Epidemiological Research on Myeloid-Derived Suppressor Cells in Ovarian Cancer: A Review of the Existing Immunological Evidence and Suggestions for Moving Forward. Frontiers in Immunology. 10: 1608. PMID 31354741 DOI: 10.3389/Fimmu.2019.01608 |
0.464 |
|
| 2019 |
Zhu Q, Zhang J, Chen Y, Hu Q, Shen H, Huang RY, Liu Q, Kaur J, Long M, Battaglia S, Eng KH, Lele SB, Zsiros E, Villella J, Lugade A, ... Moysich K, et al. Whole-Exome Sequencing Of Ovarian Cancer Families Uncovers Putative Predisposition Genes. International Journal of Cancer. PMID 31265121 DOI: 10.1002/Ijc.32545 |
0.428 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.455 |
|
| 2019 |
Di Credico G, Edefonti V, Polesel J, Pauli F, Torelli N, Serraino D, Negri E, Luce D, Stucker I, Matsuo K, Brennan P, Vilensky M, Fernandez L, Curado MP, Menezes A, ... ... Moysich K, et al. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. Oral Oncology. 94: 47-57. PMID 31178212 DOI: 10.1016/J.Oraloncology.2019.05.006 |
0.331 |
|
| 2019 |
Morrison MEW, Joseph JM, McCann SE, Tang L, Almohanna HM, Moysich KB. Cruciferous Vegetable Consumption and Stomach Cancer: A Case-Control Study. Nutrition and Cancer. 1-10. PMID 31094219 DOI: 10.1080/01635581.2019.1615100 |
0.454 |
|
| 2019 |
Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... ... Moysich K, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996 |
0.391 |
|
| 2019 |
Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... Moysich KB, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/S10552-019-01157-3 |
0.325 |
|
| 2019 |
Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB, Matsuzaki J, Koya RC, Blom AM, McLeish KR, Qu J, ... ... Moysich KB, et al. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. Jci Insight. PMID 30730851 DOI: 10.1172/Jci.Insight.122311 |
0.322 |
|
| 2019 |
Modugno F, Goughnour SL, Wallack D, Edwards RP, Odunsi K, Kelley JL, Moysich K, Ness RB, Brooks MM. Breastfeeding factors and risk of epithelial ovarian cancer. Gynecologic Oncology. PMID 30686553 DOI: 10.1016/J.Ygyno.2019.01.017 |
0.486 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... Moysich KB, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.353 |
|
| 2019 |
Mongiovi JM, Joseph JM, Minlikeeva AN, AlSulimani A, Almohanna H, Moysich KB. Abstract 641: Oral contraceptive use and risk of highly fatal ovarian cancer: Evidence from the Ovarian Cancer Association Consortium Cancer Research. 79: 641-641. DOI: 10.1158/1538-7445.Am2019-641 |
0.522 |
|
| 2019 |
Jia G, Shu X, Shu X, Long J, Cai Q, Moysich KB, Goode EL, Sellers TA, Zheng W. Abstract 598: Genetically predicted concentration of circulating proteins and epithelial ovarian cancer risk Cancer Research. 79: 598-598. DOI: 10.1158/1538-7445.Am2019-598 |
0.454 |
|
| 2018 |
Webb PM, Na R, Weiderpass E, Adami HO, Anderson KE, Bertrand KA, Botteri E, Brasky TM, Brinton LA, Chen C, Doherty JA, Lu L, McCann SE, Moysich KB, Olson S, et al. Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30566587 DOI: 10.1093/Annonc/Mdy541 |
0.485 |
|
| 2018 |
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Moysich KB, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.Can-18-2726 |
0.379 |
|
| 2018 |
Singel KL, Grzankowski KS, Khan ANMNH, Grimm MJ, D'Auria AC, Morrell K, Eng KH, Hylander B, Mayor PC, Emmons TR, Lénárt N, Fekete R, Környei Z, Muthukrishnan U, Gilthorpe JD, ... ... Moysich KB, et al. Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer. British Journal of Cancer. PMID 30518816 DOI: 10.1038/S41416-018-0339-8 |
0.377 |
|
| 2018 |
Cannioto RA, Dighe S, Mahoney MC, Moysich KB, Sen A, Hulme K, McCann SE, Ambrosone CB. Habitual recreational physical activity is associated with significantly improved survival in cancer patients: evidence from the Roswell Park Data Bank and BioRepository. Cancer Causes & Control : Ccc. PMID 30488344 DOI: 10.1007/S10552-018-1101-5 |
0.382 |
|
| 2018 |
Starbuck KD, Szender JB, Duncan WD, Morrell K, Etter JL, Zsiros E, Odunsi K, Moysich K, Eng KH. Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer. Plos One. 13: e0206913. PMID 30418985 DOI: 10.1371/Journal.Pone.0206913 |
0.414 |
|
| 2018 |
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, et al. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. PMID 30054336 DOI: 10.1158/0008-5472.Can-18-0951 |
0.412 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... Moysich KB, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.345 |
|
| 2018 |
McManus H, Moysich KB, Tang L, Joseph J, McCann SE. Usual Cruciferous Vegetable Consumption and Ovarian Cancer: A Case-Control Study. Nutrition and Cancer. 1-6. PMID 29693426 DOI: 10.1080/01635581.2018.1464346 |
0.511 |
|
| 2018 |
Cannioto R, Etter JL, LaMonte MJ, Ray AD, Joseph JM, Al Qassim E, Eng KH, Moysich KB. LIFETIME PHYSICAL INACTIVITY IS ASSOCIATED WITH LUNG CANCER RISK AND MORTALITY. Cancer Treatment and Research Communications. 14: 37-45. PMID 29632898 DOI: 10.1016/j.ctarc.2018.01.001 |
0.341 |
|
| 2018 |
Etter JL, Cannioto R, Soh KT, Alquassim E, Almohanna H, Dunbar Z, Joseph JM, Balderman S, Hernandez-Ilizaliturri F, Moysich KB. Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: A case-control study. Leukemia Research. 69: 7-11. PMID 29609041 DOI: 10.1016/j.leukres.2018.03.014 |
0.304 |
|
| 2018 |
Peres LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... Moysich K, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29584862 DOI: 10.1093/Ije/Dyy054 |
0.468 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... Moysich KB, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.401 |
|
| 2018 |
Etter JL, Eng K, Cannioto R, Kaur J, Almohanna H, Alqassim E, Szender JB, Joseph JM, Lele S, Odunsi K, Moysich KB. Hereditary association between testicular cancer and familial ovarian cancer: A Familial Ovarian Cancer Registry study. Cancer Epidemiology. 53: 184-186. PMID 29499525 DOI: 10.1016/j.canep.2018.02.005 |
0.369 |
|
| 2018 |
Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang RY, Zhu Q, Grzesik KA, Battaglia S, Cannioto R, Krolewski JJ, Zsiros E, Frederick PJ, Lele SB, Moysich KB, et al. Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. Plos Genetics. 14: e1007194. PMID 29447163 DOI: 10.1371/Journal.Pgen.1007194 |
0.389 |
|
| 2018 |
Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes & Control : Ccc. PMID 29327114 DOI: 10.1007/S10552-017-0997-5 |
0.397 |
|
| 2018 |
Natanzon Y, Köbel M, Winham SJ, Armasu SM, McCauley BM, Vierkant RA, Cunningham JM, Bowtell D, Campbell IG, Chang-Claude J, deFazio A, Fasching PA, Goodman MT, Karlan BY, Modugno F, ... Moysich KB, et al. Abstract 225: Tumor-infiltrating CD8-positive T-lymphocytes in tubo-ovarian high-grade serous cancer are associated with multiple germline variants in 22q12.1 in a genome-wide association analysis Cancer Research. 78: 225-225. DOI: 10.1158/1538-7445.Am2018-225 |
0.358 |
|
| 2018 |
Almohanna H, Joseph J, Cannioto R, Mayor P, Starbuck K, AlSulimani A, Mongiovi J, Minlikeeva A, Moysich K. Impact of physical inactivity on risk of developing highly fatal ovarian cancer: Evidence from the Ovarian Cancer Association Consortium Gynecologic Oncology. 149: 219. DOI: 10.1016/j.ygyno.2018.04.498 |
0.394 |
|
| 2018 |
Mongiovi J, Joseph J, Mayor P, Starbuck K, Minlikeeva A, AlSulimani A, Almohanna H, Moysich K. Tubal ligation and risk of highly fatal ovarian cancer: Evidence from the Ovarian Cancer Association Consortium Gynecologic Oncology. 149: 200-201. DOI: 10.1016/j.ygyno.2018.04.456 |
0.412 |
|
| 2018 |
Starbuck K, Eng K, Morrell K, Duncan W, Etter J, Moysich K, Odunsi K, Zsiros E, Frederick P, Akers S, Lele S, Szender J. Prognostic impact of adjuvant chemotherapy treatment delays for ovarian cancer: A cohort study Gynecologic Oncology. 149: 127-128. DOI: 10.1016/j.ygyno.2018.04.294 |
0.305 |
|
| 2018 |
Singel K, Khan AN, Ram S, Moysich K, Odunsi K, Zsiros E, Segal B. Mature neutrophils suppress T cell immunity in the ovarian cancer microenvironment via C3 activation Molecular Immunology. 102: 215. DOI: 10.1016/J.Molimm.2018.06.216 |
0.359 |
|
| 2017 |
Lin T, Zirpoli GR, McCann SE, Moysich KB, Ambrosone CB, Tang L. Trends in Cruciferous Vegetable Consumption and Associations with Breast Cancer Risk: A Case-Control Study. Current Developments in Nutrition. 1: e000448. PMID 29955715 DOI: 10.3945/cdn.117.000448 |
0.383 |
|
| 2017 |
Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... Moysich K, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29211900 DOI: 10.1093/ije/dyx252 |
0.371 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.497 |
|
| 2017 |
Glubb DM, Johnatty SE, Quinn MCJ, O'Mara TA, Tyrer JP, Gao B, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Velez Edwards DR, Beeghly-Fadiel A, Benitez J, Garcia MJ, Goodman MT, ... ... Moysich K, et al. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. Oncotarget. 8: 64670-64684. PMID 29029385 DOI: 10.18632/Oncotarget.18501 |
0.381 |
|
| 2017 |
Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, ... ... Moysich KB, et al. Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget. 8: 50930-50940. PMID 28881617 DOI: 10.18632/Oncotarget.15871 |
0.417 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Moysich KB, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.Epi-17-0367 |
0.364 |
|
| 2017 |
Babic A, Harris HR, Vitonis AF, Titus LJ, Jordan SJ, Webb PM, Risch HA, Rossing MA, Doherty JA, Wicklund K, Goodman MT, Modugno F, Moysich KB, Ness R, et al. Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium. International Journal of Cancer. PMID 28833087 DOI: 10.1002/Ijc.31010 |
0.425 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, ... Moysich KB, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British Journal of Cancer. PMID 28817835 DOI: 10.1038/Bjc.2017.267 |
0.314 |
|
| 2017 |
Platek AJ, Cannioto RA, Etter JL, Kim J, Joseph JM, Gulati NR, Schmitt KL, Callahan E, Khachatryan E, Nagy R, Minlikeeva A, Brian Szender J, Singh AK, Danziger I, Moysich KB. The association of lifetime physical inactivity with head and neck cancer: a hospital-based case-control analysis. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. PMID 28780667 DOI: 10.1007/s00405-017-4688-3 |
0.344 |
|
| 2017 |
Nwizu NN, Marshall JR, Moysich K, Genco RJ, Hovey KM, Mai X, LaMonte MJ, Freudenheim JL, Wactawski-Wende J. Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1255-1265. PMID 28765338 DOI: 10.1158/1055-9965.Epi-17-0212 |
0.497 |
|
| 2017 |
Kawakita D, Amy Lee YC, Turati F, Parpinel M, Decarli A, Serraino D, Matsuo K, Olshan AF, Zevallos JP, Winn DM, Moysich K, Zhang ZF, Morgenstern H, Levi F, Kelsey K, et al. Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium. International Journal of Cancer. PMID 28710831 DOI: 10.1002/Ijc.30886 |
0.456 |
|
| 2017 |
Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, Khan ANMN, Singel KL, Mayor PC, Moysich KB, Odunsi K, Segal BH, Eng KH. Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecologic Oncology. PMID 28624153 DOI: 10.1016/J.Ygyno.2017.06.008 |
0.393 |
|
| 2017 |
Kar SP, Berchuck A, Gayther SA, Goode EL, Moysich KB, Pearce CL, Ramus SJ, Schildkraut JM, Sellers TA, Pharoah PDP. Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28615364 DOI: 10.1158/1055-9965.Epi-17-0315 |
0.438 |
|
| 2017 |
Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, Fuleihan R, Garabedian E, Lugar P, Ochs HD, Bonilla FA, Buckley RH, Sullivan KE, Ballas ZK, Cunningham-Rundles C, et al. Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. The Journal of Allergy and Clinical Immunology. PMID 28606585 DOI: 10.1016/J.Jaci.2017.05.024 |
0.395 |
|
| 2017 |
Cannioto R, Etter JL, Guterman LB, Joseph JM, Gulati NR, Schmitt KL, LaMonte MJ, Nagy R, Minlikeeva A, Szender JB, Moysich KB. The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis. Cancer Epidemiology. 49: 24-29. PMID 28528291 DOI: 10.1016/j.canep.2017.04.017 |
0.345 |
|
| 2017 |
Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057 |
0.414 |
|
| 2017 |
Dicks E, Song H, Ramus SJ, Van Oudenhove E, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Study Group A, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, ... Moysich KB, et al. Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget. PMID 28404948 DOI: 10.18632/oncotarget.15871 |
0.302 |
|
| 2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.36 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, ... Moysich KB, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes & Control : Ccc. PMID 28293802 DOI: 10.1007/S10552-017-0867-1 |
0.451 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... Moysich KB, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.355 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.3 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.416 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Moysich K, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.384 |
|
| 2016 |
Cannioto RA, Sucheston-Campbell LE, Hampras S, Goode EL, Knutson K, Ness R, Modugno F, Wallace PK, Szender JB, Mayor P, Hong CC, Joseph JM, Friel G, Davis W, Nesline M, ... Moysich KB, et al. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 27759594 DOI: 10.1097/Igc.0000000000000845 |
0.756 |
|
| 2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... Moysich KB, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.301 |
|
| 2016 |
Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Moysich KB, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.Epi-16-0631 |
0.313 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... Moysich KB, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.327 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... Moysich KB, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.348 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... Moysich KB, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.304 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... Moysich KB, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.76 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... Moysich KB, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.386 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/Ijc.30274 |
0.499 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... Moysich KB, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.488 |
|
| 2016 |
Goossens ME, Isa F, Brinkman M, Mak D, Reulen R, Wesselius A, Benhamou S, Bosetti C, Bueno-de-Mesquita B, Carta A, Allam MF, Golka K, Grant EJ, Jiang X, Johnson KC, ... Moysich K, et al. International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics. Archives of Public Health = Archives Belges De Sante Publique. 74: 30. PMID 27386115 DOI: 10.1186/S13690-016-0140-1 |
0.435 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Moysich KB, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.403 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... Moysich KB, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.471 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... Moysich KB, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.382 |
|
| 2016 |
Szender JB, Cannioto R, Gulati NR, Schmitt KL, Friel G, Minlikeeva A, Platek A, Gower EH, Nagy R, Khachatryan E, Mayor PC, Kasza KA, Lele SB, Odunsi K, Moysich KB. Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study. Journal of Lower Genital Tract Disease. PMID 27105330 DOI: 10.1097/Lgt.0000000000000210 |
0.48 |
|
| 2016 |
Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, ... Moysich KB, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/01.Ogx.0000489579.62561.B8 |
0.344 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... Moysich KB, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.374 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.302 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... Moysich KB, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.331 |
|
| 2016 |
Pharoah PD, Song H, Dicks E, Intermaggio MP, Harrington P, Baynes C, Alsop K, Bogdanova N, Cicek MS, Cunningham JM, Fridley BL, Gentry-Maharaj A, Hillemanns P, Lele S, ... ... Moysich KB, et al. PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. Journal of the National Cancer Institute. 108. PMID 26823519 DOI: 10.1093/Jnci/Djv347 |
0.357 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... Moysich KB, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.348 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... Moysich KB, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.483 |
|
| 2016 |
Mayor P, Eng KH, Singel KL, Abrams SI, Moysich KB, Odunsi K, Cunningham-Rundles C, Segal BH. Cancer in primary immunodeficiency diseases: An analysis of cancer incidence in the United States immune deficiency network (USIDNET) registry. Journal of Clinical Oncology. 34: 1520-1520. DOI: 10.1200/Jco.2016.34.15_Suppl.1520 |
0.466 |
|
| 2016 |
Minlikeeva AN, Freudenheim JL, Pearce CL, Szender JB, Moysich KB. Abstract B24: Personal history of endometriosis and survival in ovarian cancer patients: A pooled analysis of 10 studies from the Ovarian Cancer Association Consortium. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B24 |
0.521 |
|
| 2016 |
Cannioto RA, LaMonte M, Moysich KB. Abstract B18: Prediagnostic physical inactivity and epithelial ovarian cancer risk and mortality: Evidence from the Ovarian Cancer Association Consortium. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B18 |
0.485 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Cancer Research. 76: 797-797. DOI: 10.1158/1538-7445.Am2016-797 |
0.472 |
|
| 2016 |
Minlikeeva A, Freudenheim JL, Moysich KB. Abstract 2638: Cardiovascular comorbidity and ovarian cancer patient survival: history of hypertension, heart disease, and diabetes, evidence from the Ovarian Cancer Association Consortium Cancer Research. 76: 2638-2638. DOI: 10.1158/1538-7445.Am2016-2638 |
0.481 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli G, Bandera EV, Berchuck A, ... Moysich KB, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Obstetrical and Gynecological Survey. 71: 528-530. DOI: 10.1097/Ogx.0000000000000357 |
0.36 |
|
| 2016 |
Szender J, Mayor P, Frederick P, Moysich K, Odunsi K, Lele S. Evaluation of smoking as a risk factor for adverse postoperative outcomes in endometrial cancer: A study of the NSQIP database Gynecologic Oncology. 141: 166-167. DOI: 10.1016/J.Ygyno.2016.04.433 |
0.389 |
|
| 2016 |
Szender J, Mayor P, Zsiros E, Moysich K, Lele S, Odunsi K. Evaluating determinants of prolonged hospitalization following minimally invasive surgery for endometrial cancer Gynecologic Oncology. 141: 164. DOI: 10.1016/J.Ygyno.2016.04.427 |
0.34 |
|
| 2016 |
Szender J, Grzankowski K, Frederick P, Moysich K, Odunsi K, Lele S. Surgical specialty affects the risk of postoperative complications in ovarian cancer: An analysis of the ACS-NSQIP datasets Gynecologic Oncology. 141: 162. DOI: 10.1016/J.Ygyno.2016.04.422 |
0.416 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... Moysich KB, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.407 |
|
| 2015 |
Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, Dunning AM, Easton DF, Wang Q, Benitez J, Hopper JL, Southey MC, Schmidt MK, Broeks A, et al. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Human Genetics. PMID 26621531 DOI: 10.1007/S00439-015-1616-8 |
0.458 |
|
| 2015 |
Brightwell RM, Grzankowski KS, Kaur J, Poblete S, Miller A, Lele SB, Sucheston-Campbell L, Moysich K, Odunsi KO. Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry. American Journal of Clinical and Experimental Obstetrics and Gynecology. 2: 39-44. PMID 26605374 |
0.322 |
|
| 2015 |
Costas L, Lambert BH, Birmann BM, Moysich KB, De Roos AJ, Hofmann JN, Baris D, Wang SS, Camp NJ, Tricot G, Atanackovic D, Brennan P, Cocco P, Nieters A, Becker N, et al. A pooled analysis of reproductive factors, exogenous hormone use and risk of multiple myeloma among women in the International Multiple Myeloma Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26464426 DOI: 10.1158/1055-9965.Epi-15-0953 |
0.335 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Moysich KB, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.303 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Moysich KB, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.323 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... Moysich KB, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.33 |
|
| 2015 |
Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, Fraser L, Gentry-Maharaj A, Hayward J, Philpott S, Anderson C, Edlund CK, Conti D, Harrington P, Barrowdale D, ... Moysich KB, et al. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. Journal of the National Cancer Institute. 107. PMID 26315354 DOI: 10.1093/Jnci/Djv214 |
0.447 |
|
| 2015 |
Knutson KL, Maurer MJ, Preston CC, Moysich KB, Goergen K, Hawthorne KM, Cunningham JM, Odunsi K, Hartmann LC, Kalli KR, Oberg AL, Goode EL. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer. Cancer Immunology, Immunotherapy : Cii. PMID 26298430 DOI: 10.1007/S00262-015-1753-X |
0.378 |
|
| 2015 |
Kolomeyevskaya NV, Szender JB, Zirpoli G, Minlikeeva A, Friel G, Cannioto RA, Brightwell RM, Grzankowski KS, Moysich KB. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 1587-92. PMID 26273932 DOI: 10.1097/Igc.0000000000000540 |
0.443 |
|
| 2015 |
Song H, Dicks E, Ramus SJ, Tyrer JP, Intermaggio MP, Hayward J, Edlund CK, Conti D, Harrington P, Fraser L, Philpott S, Anderson C, Rosenthal A, Gentry-Maharaj A, Bowtell DD, ... Moysich KB, et al. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2901-7. PMID 26261251 DOI: 10.1200/Jco.2015.61.2408 |
0.427 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... Moysich KB, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.355 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... Moysich KB, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.32 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... Moysich KB, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.46 |
|
| 2015 |
Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, ... Moysich K, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 26151456 DOI: 10.1038/Bjc.2015.245 |
0.35 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... Moysich KB, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.357 |
|
| 2015 |
Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB. Use of common analgesics is not associated with ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26063476 DOI: 10.1158/1055-9965.Epi-15-0508 |
0.501 |
|
| 2015 |
Kolomeyevskaya N, Eng KH, Khan AN, Grzankowski KS, Singel KL, Moysich K, Segal BH. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecologic Oncology. PMID 26001328 DOI: 10.1016/J.Ygyno.2015.05.009 |
0.358 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Moysich KB, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.377 |
|
| 2015 |
Leoncini E, Edefonti V, Hashibe M, Parpinel M, Cadoni G, Ferraroni M, Serraino D, Matsuo K, Olshan AF, Zevallos JP, Winn DM, Moysich K, Zhang ZF, Morgenstern H, Levi F, et al. Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. European Journal of Epidemiology. PMID 25930054 DOI: 10.1007/S10654-015-0036-3 |
0.459 |
|
| 2015 |
Clay A, Peoples B, Zhang Y, Moysich K, Ross L, McCarthy P, Hahn T. Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by Race. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1488-94. PMID 25899454 DOI: 10.1016/J.Bbmt.2015.04.017 |
0.319 |
|
| 2015 |
Khan AN, Kolomeyevskaya N, Singel KL, Grimm MJ, Moysich KB, Daudi S, Grzankowski KS, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer. Oncotarget. 6: 11310-26. PMID 25888637 DOI: 10.18632/Oncotarget.3597 |
0.311 |
|
| 2015 |
Friel G, Liu CS, Kolomeyevskaya NV, Hampras SS, Kruszka B, Schmitt K, Cannioto RA, Lele SB, Odunsi KO, Moysich KB. Aspirin and Acetaminophen Use and the Risk of Cervical Cancer. Journal of Lower Genital Tract Disease. 19: 189-93. PMID 25856123 DOI: 10.1097/Lgt.0000000000000104 |
0.776 |
|
| 2015 |
Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, Seibold P, Fasching PA, Andrulis IL, Kristensen VN, Couch FJ, Hamann U, Hooning MJ, Nevanlinna H, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Research : Bcr. 17: 18. PMID 25849327 DOI: 10.1186/s13058-015-0522-2 |
0.335 |
|
| 2015 |
Cannioto RA, Moysich KB. Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription. Gynecologic Oncology. 137: 559-73. PMID 25797080 DOI: 10.1016/J.Ygyno.2015.03.016 |
0.431 |
|
| 2015 |
Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, Cerhan JR, Clendenen TV, Felix AS, Friedenreich CM, Garcia-Closas M, Goodman MT, Liang X, Lissowska J, Lu L, ... ... Moysich KB, et al. Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). British Journal of Cancer. 112: 925-33. PMID 25688738 DOI: 10.1038/Bjc.2015.24 |
0.405 |
|
| 2015 |
Edefonti V, Hashibe M, Parpinel M, Turati F, Serraino D, Matsuo K, Olshan AF, Zevallos JP, Winn DM, Moysich K, Zhang ZF, Morgenstern H, Levi F, Kelsey K, McClean M, et al. Natural vitamin C intake and the risk of head and neck cancer: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. International Journal of Cancer. Journal International Du Cancer. 137: 448-62. PMID 25627906 DOI: 10.1002/Ijc.29388 |
0.452 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... Moysich KB, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.33 |
|
| 2015 |
Candido-dos-Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL, Larson MC, Alsop K, Dicks E, Harrington P, Ramus SJ, de Fazio A, Mitchell G, Fereday S, Bolton KL, Gourley C, ... ... Moysich K, et al. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 652-7. PMID 25398451 DOI: 10.1158/1078-0432.Ccr-14-2497 |
0.402 |
|
| 2015 |
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532 |
0.411 |
|
| 2015 |
Conway DI, Brenner DR, McMahon AD, Macpherson LM, Agudo A, Ahrens W, Bosetti C, Brenner H, Castellsague X, Chen C, Curado MP, Curioni OA, Dal Maso L, Daudt AW, de Gois Filho JF, ... Moysich K, et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. International Journal of Cancer. Journal International Du Cancer. 136: 1125-39. PMID 24996155 DOI: 10.1002/Ijc.29063 |
0.456 |
|
| 2015 |
Galeone C, Edefonti V, Parpinel M, Leoncini E, Matsuo K, Talamini R, Olshan AF, Zevallos JP, Winn DM, Jayaprakash V, Moysich K, Zhang ZF, Morgenstern H, Levi F, Bosetti C, et al. Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology Consortium. International Journal of Cancer. Journal International Du Cancer. 136: 904-14. PMID 24974959 DOI: 10.1002/Ijc.29044 |
0.459 |
|
| 2015 |
Kolomeyevskaya N, Zirpoli G, Ruszczyk M, Grzankowski K, Lele S, Odunsi K, Moysich K. Oral contraceptive use and reproductive characteristics affect survival in patients with epithelial ovarian cancer Gynecologic Oncology. 137: 104. DOI: 10.1016/J.Ygyno.2015.01.259 |
0.413 |
|
| 2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.459 |
|
| 2014 |
Akers SN, Moysich K, Zhang W, Collamat Lai G, Miller A, Lele S, Odunsi K, Karpf AR. LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecologic Oncology. 132: 462-7. PMID 24374023 DOI: 10.1016/J.Ygyno.2013.12.024 |
0.364 |
|
| 2014 |
Hampras SS, Moysich KB, Marimuthu SP, Ravi V, Jayaprakash V. Socioeconomic factors and the risk for sarcoma. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 23: 560-5. PMID 24356343 DOI: 10.1097/Cej.0000000000000004 |
0.746 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... Moysich K, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.514 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... Moysich KB, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.456 |
|
| 2014 |
Grzankowski KS, Khan ANH, Eng KH, Grimm M, Singel KL, Kolomeyevskaya N, Moysich KB, Odunsi K, Segal BH. Pretreatment serum mitochondrial DNA (mtDNA) correlates with shorter progression-free and overall survival in patients with advanced ovarian cancer (OC). Journal of Clinical Oncology. 32: 5545-5545. DOI: 10.1200/Jco.2014.32.15_Suppl.5545 |
0.304 |
|
| 2014 |
Kurta M, Edwards R, Moysich K, McDonough K, Bertolet M, Weissfeld J, Catov J, Modugno F, Bunker C, Ness R, Diergaarde B. Abstract LB-273: Prognosis and conditional disease-free survival among ovarian cancer patients Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-273 |
0.382 |
|
| 2014 |
Liu C, Friel G, Kolomeyevskaya N, Lele S, Odunsi K, Moysich K. Aspirin and acetaminophen decrease the risk of cervical cancer in long-term users Gynecologic Oncology. 133: 42-43. DOI: 10.1016/J.Ygyno.2014.03.123 |
0.385 |
|
| 2013 |
Tian CQ, Darcy KM, Krivak TC, Deloia JA, Armstrong D, Davis W, Zhao H, Moysich K, Ambrosone CB. Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study. Frontiers in Oncology. 3: 206. PMID 23964347 DOI: 10.3389/Fonc.2013.00206 |
0.436 |
|
| 2013 |
Andreotti G, Birmann B, De Roos AJ, Spinelli J, Cozen W, Camp NJ, Moysich K, Chiu B, Steplowski E, Krzystan J, Boffetta P, Benhaim-Luzon V, Brennan P, de Sanjosé S, Costas L, et al. A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1620-7. PMID 23964064 DOI: 10.1158/1055-9965.Epi-13-0334 |
0.328 |
|
| 2013 |
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research (Philadelphia, Pa.). 6: 811-21. PMID 23761272 DOI: 10.1158/1940-6207.Capr-13-0037 |
0.514 |
|
| 2013 |
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology. 42: 579-89. PMID 23569193 DOI: 10.1093/Ije/Dyt042 |
0.508 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... Moysich KB, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.445 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Moysich KB, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.414 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... Moysich KB, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.504 |
|
| 2013 |
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, ... Moysich K, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T |
0.445 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... Moysich KB, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.466 |
|
| 2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, ... Moysich K, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.421 |
|
| 2013 |
Goode EL, DeRycke M, Kalli KR, Oberg AL, Cunningham JM, Maurer MJ, Fridley BL, Armasu SM, Serie DJ, Ramar P, Goergen K, Vierkant RA, Rider DN, Sicotte H, Wang C, ... ... Moysich KB, et al. Inherited variants in regulatory T cell genes and outcome of ovarian cancer. Plos One. 8: e53903. PMID 23382860 DOI: 10.1371/Journal.Pone.0053903 |
0.741 |
|
| 2013 |
Brasky TM, Moysich KB, Cohn DE, White E. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecologic Oncology. 128: 113-9. PMID 23063765 DOI: 10.1016/J.Ygyno.2012.10.005 |
0.426 |
|
| 2013 |
Charbonneau B, Knutson K, Vierkant RA, Cunningham JM, Fogarty ZC, Kalli KR, Maurer MJ, Oberg AL, Fridley BL, Preston CC, Pharoah PDP, Ramus SJ, Phelan CM, Odunsi K, Moysich K, et al. Abstract 4844: Polymorphisms in regulatory T cell related genes and ovarian cancer survival. Cancer Research. 73: 4844-4844. DOI: 10.1158/1538-7445.Am2013-4844 |
0.464 |
|
| 2012 |
Obermajer N, Wong JL, Edwards RP, Odunsi K, Moysich K, Kalinski P. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunological Investigations. 41: 635-57. PMID 23017139 DOI: 10.3109/08820139.2012.695417 |
0.349 |
|
| 2012 |
Hampras SS, Nesline M, Wallace PK, Odunsi K, Furlani N, Davis W, Moysich KB. Predictors of immunosuppressive regulatory T lymphocytes in healthy women. Journal of Cancer Epidemiology. 2012: 191090. PMID 22969801 DOI: 10.1155/2012/191090 |
0.742 |
|
| 2012 |
Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, ... Moysich KB, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American Journal of Epidemiology. 176: 269-78. PMID 22831825 DOI: 10.1093/Aje/Kws129 |
0.483 |
|
| 2012 |
Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1282-92. PMID 22707710 DOI: 10.1158/1055-9965.Epi-12-0426 |
0.503 |
|
| 2012 |
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, ... Moysich K, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet. Oncology. 13: 385-94. PMID 22361336 DOI: 10.1016/S1470-2045(11)70404-1 |
0.511 |
|
| 2012 |
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, BenÃtez J, GarcÃa MJ, ... ... Moysich KB, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Jama. 307: 382-90. PMID 22274685 DOI: 10.1001/Jama.2012.20 |
0.419 |
|
| 2012 |
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, ... ... Moysich KB, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025 |
0.5 |
|
| 2012 |
Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology (Cambridge, Mass.). 23: 311-9. PMID 22252409 DOI: 10.1097/Ede.0B013E3182456Ad3 |
0.396 |
|
| 2012 |
Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecologic Oncology. 124: 575-81. PMID 22112610 DOI: 10.1016/J.Ygyno.2011.11.022 |
0.423 |
|
| 2012 |
Jayaprakash V, Loewen GM, Dhillon SS, Moysich KB, Mahoney MC, Yendamuri S, Hogarth DK, Reid ME. Early Detection of Lung Cancer Using CT Scan and Bronchoscopy in a High Risk Population Journal of Cancer Therapy. 3: 388-396. DOI: 10.4236/Jct.2012.324051 |
0.318 |
|
| 2012 |
Setiawan VW, Yang HP, Pike MC, McCann S, Yu H, Xiang Y, Wolk A, Wentzensen N, Weiss NS, Webb PM, Brandt PAvd, Vijver Kvd, Thompson PJ, Strom BL, Spurdle AB, ... ... Moysich KB, et al. Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 Epidemiology. 72: 1029-1029. DOI: 10.1158/1538-7445.Am2012-1029 |
0.432 |
|
| 2011 |
Marimuthu SP, Vijayaragavan P, Moysich KB, Jayaprakash V. Diabetes mellitus and gastric carcinoma: Is there an association? Journal of Carcinogenesis. 10: 30. PMID 22190872 DOI: 10.4103/1477-3163.90481 |
0.338 |
|
| 2011 |
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... Moysich KB, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052 |
0.411 |
|
| 2011 |
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... Moysich KB, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388 |
0.438 |
|
| 2011 |
Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J, Mi S, O'Donnell PH, Fraiman YS, Das S, Cox NJ, ... ... Moysich KB, et al. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5490-500. PMID 21705454 DOI: 10.1158/1078-0432.Ccr-11-0724 |
0.411 |
|
| 2011 |
Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes & Control : Ccc. 22: 965-75. PMID 21516318 DOI: 10.1007/S10552-011-9769-9 |
0.47 |
|
| 2011 |
Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics. 20: 2263-72. PMID 21422097 DOI: 10.1093/Hmg/Ddr087 |
0.511 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... Moysich KB, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.516 |
|
| 2011 |
Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, ... Moysich KB, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 103: 105-16. PMID 21169536 DOI: 10.1093/Jnci/Djq494 |
0.401 |
|
| 2011 |
Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Annals of Epidemiology. 21: 188-96. PMID 21109450 DOI: 10.1016/J.Annepidem.2010.10.002 |
0.452 |
|
| 2011 |
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, ... ... Moysich K, et al. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility. 95: 40-5. PMID 20719308 DOI: 10.1016/J.Fertnstert.2010.06.059 |
0.321 |
|
| 2011 |
Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Research and Treatment. 126: 157-65. PMID 20676755 DOI: 10.1007/S10549-010-1082-X |
0.475 |
|
| 2011 |
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, ... Moysich KB, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 128: 2063-74. PMID 20635389 DOI: 10.1002/Ijc.25554 |
0.469 |
|
| 2011 |
Andreotti G, Benhaim-Luzon V, Brennan P, Sanjose Sd, Caudet LC, Costantini AS, Cocco P, Becker N, Foretova L, Maynadie M, Nieters A, Birmann B, Staines A, Miliken K, Weisenburger D, ... ... Moysich K, et al. Abstract B115: A pooled analysis of smoking and alcohol drinking and risk of multiple myeloma in the International Multiple Myeloma Consortium Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B115 |
0.377 |
|
| 2011 |
Bolton KL, Goh C, Ramus S, Goldgar D, Benitez J, Osorio A, Easton D, Peock S, Godwin A, Kwong A, Blanco I, Goode E, Greene M, Loud J, Mai P, ... ... Moysich K, et al. Abstract 2752: Genetic heterogeneity of ovarian cancer survival effects inBRCA1/2germline mutations: a large, multi-center study Epidemiology. 71: 2752-2752. DOI: 10.1158/1538-7445.Am2011-2752 |
0.379 |
|
| 2011 |
Akers S, Moysich K, Zhang W, Link P, Miller A, Lele S, Odunsi K, Karpf A. Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer Gynecologic Oncology. 120: S43-S44. DOI: 10.1016/J.Ygyno.2010.12.107 |
0.467 |
|
| 2010 |
Kuptsova-Clarkson N, Ambrosone CB, Weiss J, Baer MR, Sucheston LE, Zirpoli G, Kopecky KJ, Ford L, Blanco J, Wetzler M, Moysich KB. XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. International Journal of Molecular Epidemiology and Genetics. 1: 278-94. PMID 21394217 |
0.642 |
|
| 2010 |
Hampras SS, Sucheston L, Weiss J, Baer MR, Zirpoli G, Singh PK, Wetzler M, Chennamaneni R, Blanco JG, Ford L, Moysich KB. Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia. International Journal of Molecular Epidemiology and Genetics. 1: 201-7. PMID 21311724 |
0.779 |
|
| 2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... Moysich KB, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.429 |
|
| 2010 |
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, ... Moysich KB, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Plos Genetics. 6: e1001016. PMID 20628624 DOI: 10.1371/Journal.Pgen.1001016 |
0.479 |
|
| 2010 |
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, ... Moysich K, et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1822-30. PMID 20570913 DOI: 10.1158/1055-9965.Epi-09-1317 |
0.406 |
|
| 2010 |
Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE. Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1806-11. PMID 20551305 DOI: 10.1158/1055-9965.Epi-10-0008 |
0.483 |
|
| 2010 |
Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes & Control : Ccc. 21: 1503-12. PMID 20499154 DOI: 10.1007/S10552-010-9579-5 |
0.47 |
|
| 2010 |
Tang L, Zirpoli GR, Jayaprakash V, Reid ME, McCann SE, Nwogu CE, Zhang Y, Ambrosone CB, Moysich KB. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. Bmc Cancer. 10: 162. PMID 20423504 DOI: 10.1186/1471-2407-10-162 |
0.402 |
|
| 2010 |
Peppone LJ, Reid ME, Moysich KB, Morrow GR, Jean-Pierre P, Mohile SG, Darling TV, Hyland A. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer Causes & Control : Ccc. 21: 1247-55. PMID 20376547 DOI: 10.1007/S10552-010-9552-3 |
0.388 |
|
| 2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.503 |
|
| 2010 |
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 245-50. PMID 20056644 DOI: 10.1158/1055-9965.Epi-09-0729 |
0.493 |
|
| 2010 |
Jayaprakash V, Loewen G, Mahoney M, Moysich K, Yendamuri S, Hutson A, Hogarth K, Menezes R, Mary R. Abstract A21: Lung cancer surveillance with CT scan and autofluorescence bronchoscopy Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A21 |
0.448 |
|
| 2010 |
Akers SN, Moysich K, Zhang W, Link PA, Lele S, Odunsi K, Karpf AR. Abstract LB-87: Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer Cellular and Molecular Biology. 70. DOI: 10.1158/1538-7445.Am10-Lb-87 |
0.465 |
|
| 2009 |
Darcy KM, Tian C, Ambrosone CB, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, DeLoia JA. A Gynecologic Oncology Group study of associations between polymorphisms in ABC transporter genes (ABCB1, ABCC2, and ABCG2) and outcome in advanced stage epithelial ovarian cancer treated with platinum and taxane chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5567. PMID 27962559 DOI: 10.1200/Jco.2009.27.15_Suppl.5567 |
0.38 |
|
| 2009 |
Jayaprakash V, Sullivan M, Merzianu M, Rigual NR, Loree TR, Popat SR, Moysich KB, Ramananda S, Johnson T, Marshall JR, Hutson AD, Mang TS, Wilson BC, Gill SR, Frustino J, et al. Autofluorescence-guided surveillance for oral cancer. Cancer Prevention Research (Philadelphia, Pa.). 2: 966-74. PMID 19892665 DOI: 10.1158/1940-6207.Capr-09-0062 |
0.319 |
|
| 2009 |
Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data. Cancer Epidemiology. 33: 182-8. PMID 19683487 DOI: 10.1016/J.Canep.2009.07.004 |
0.39 |
|
| 2009 |
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... Moysich K, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 |
0.465 |
|
| 2009 |
Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM, Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, Moysich K, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 12: 269-75. PMID 19456219 DOI: 10.1375/Twin.12.3.269 |
0.49 |
|
| 2009 |
Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, ... Moysich K, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138 |
0.523 |
|
| 2009 |
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947 |
0.342 |
|
| 2009 |
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, ... ... Moysich KB, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820 |
0.379 |
|
| 2009 |
McCann SE, Yeh M, Rodabaugh K, Moysich KB. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. International Journal of Cancer. 124: 1650-3. PMID 19107932 DOI: 10.1002/Ijc.24125 |
0.516 |
|
| 2009 |
Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Graham S, Brasure JR, McCann SE. Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks. The Journal of Nutrition. 139: 317-22. PMID 19074206 DOI: 10.3945/Jn.108.099960 |
0.439 |
|
| 2009 |
Kuptsova-Clarkson N, Ambrosone C, Weiss J, Baer MR, Sucheston L, Zirpoli G, Kopecky K, Ford LA, Blanco J, Wetzler M, Moysich K. XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML). Blood. 114: 168-168. DOI: 10.1182/Blood.V114.22.168.168 |
0.694 |
|
| 2009 |
Sucheston L, Choi J, Laden F, Mililkan R, Zirpoli G, Grasela M, Gammon M, Teitelbaum S, Wolff M, Zhang T, Moysich K. Pooled Analyses of Polychlorinated Biphenyls (PCBs) Exposure and CYP1A1 Genetic Polymorphisms on Breast Cancer Risk Epidemiology. 20: S188. DOI: 10.1097/01.Ede.0000362634.68221.F0 |
0.432 |
|
| 2008 |
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, ... Moysich KB, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548 |
0.489 |
|
| 2008 |
Moysich KB, Beehler GP, Zirpoli G, Choi JY, Baker JA. Use of common medications and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1564-95. PMID 18628410 DOI: 10.1158/1055-9965.Epi-07-2828 |
0.429 |
|
| 2008 |
Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Female adolescents' perceptions of male partners' pregnancy desire. Journal of Midwifery & Women's Health. 53: 338-44. PMID 18586187 DOI: 10.1016/J.Jmwh.2007.12.002 |
0.633 |
|
| 2008 |
Menezes RJ, Cheney RT, Husain A, Tretiakova M, Loewen G, Johnson CS, Jayaprakash V, Moysich KB, Salgia R, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1104-10. PMID 18483332 DOI: 10.1158/1055-9965.Epi-07-2713 |
0.338 |
|
| 2008 |
Padmanabhan A, Baker JA, Zirpoli G, Sait SN, Ford LA, Moysich KB, Baer MR. Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members. Leukemia Research. 32: 1820-3. PMID 18468682 DOI: 10.1016/J.Leukres.2008.03.032 |
0.479 |
|
| 2008 |
Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and Cancer. 60: 331-41. PMID 18444167 DOI: 10.1080/01635580701861769 |
0.433 |
|
| 2008 |
Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, ... Moysich KB, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 123: 380-8. PMID 18431743 DOI: 10.1002/Ijc.23448 |
0.475 |
|
| 2008 |
Tang L, Zirpoli GR, Guru K, Moysich KB, Zhang Y, Ambrosone CB, McCann SE. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 938-44. PMID 18398034 DOI: 10.1158/1055-9965.Epi-07-2502 |
0.524 |
|
| 2008 |
Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Differences in pregnancy desire among pregnant female adolescents at a state-funded family planning clinic. Journal of Midwifery & Women's Health. 53: 130-7. PMID 18308262 DOI: 10.1016/J.Jmwh.2007.09.005 |
0.649 |
|
| 2008 |
Peppone LJ, Mahoney MC, Cummings KM, Michalek AM, Reid ME, Moysich KB, Hyland A. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. Journal of Cancer Research and Clinical Oncology. 134: 743-51. PMID 18264728 DOI: 10.1007/S00432-007-0332-8 |
0.382 |
|
| 2008 |
Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, ... Moysich K, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British Journal of Cancer. 98: 282-8. PMID 18219286 DOI: 10.1038/Sj.Bjc.6604170 |
0.451 |
|
| 2008 |
Jayaprakash V, Natarajan KK, Moysich KB, Rigual NR, Ramnath N, Natarajan N, Reid ME. Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occupational and Environmental Medicine. 65: 647-54. PMID 18182588 DOI: 10.1136/Oem.2007.036210 |
0.502 |
|
| 2008 |
Heavey EJ, Moysich KB, Hyland A, Druschel CM, Sill MW. Differences in contraceptive choice among female adolescents at a state-funded family planning clinic. Journal of Midwifery & Women's Health. 53: 45-52. PMID 18164433 DOI: 10.1016/J.Jmwh.2007.07.010 |
0.646 |
|
| 2008 |
Peppone LJ, Moysich KB, Reid ME, Morrow GR, Hyland A. Colorectal cancer risk from cigarette smoking increases over 5 decades Journal of Clinical Oncology. 26: 1527-1527. DOI: 10.1200/Jco.2008.26.15_Suppl.1527 |
0.451 |
|
| 2008 |
Jayaprakash V, Loewen G, Moysich K, Yendamuri S, Hutson A, Menezes R, Reid M. Abstract B55: Factors predicting the progression of premalignant bronchial lesions Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B55 |
0.366 |
|
| 2008 |
Tang L, Zirpoli G, Reid M, McCann S, Nwogu C, Zhang Y, Ambrosone C, Moysich K. Abstract B132: Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B132 |
0.412 |
|
| 2007 |
Weiss JR, Baer MR, Ambrosone CB, Blanco JG, Hutson A, Ford LA, Moysich KB. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1038-41. PMID 17507636 DOI: 10.1158/1055-9965.Epi-06-0964 |
0.647 |
|
| 2007 |
Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S. Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer. 109: 2627-34. PMID 17503444 DOI: 10.1002/Cncr.22656 |
0.418 |
|
| 2007 |
Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer: epidemiologic studies. Cancer. 109: 2667-711. PMID 17503436 DOI: 10.1002/Cncr.22655 |
0.419 |
|
| 2007 |
Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer. 109: 2712-49. PMID 17503428 DOI: 10.1002/Cncr.22654 |
0.406 |
|
| 2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... Moysich KB, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.329 |
|
| 2007 |
Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, McCann SE, Villella JA. Usual adult body mass index is not predictive of ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 626-8. PMID 17372264 DOI: 10.1158/1055-9965.Epi-06-1052 |
0.429 |
|
| 2007 |
Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 17: 50-4. PMID 17291231 DOI: 10.1111/J.1525-1438.2006.00773.X |
0.525 |
|
| 2007 |
Moysich KB, Bonner MR, Beehler GP, Marshall JR, Menezes RJ, Baker JA, Weiss JR, Chanan-Khan A. Regular analgesic use and risk of multiple myeloma. Leukemia Research. 31: 547-51. PMID 16962170 DOI: 10.1016/J.Leukres.2006.07.027 |
0.694 |
|
| 2007 |
Padmanabhan A, Block A, Sait S, Ford LA, O'Connor TL, Moysich KB, Baer MR. Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer Journal of Clinical Oncology. 25: 7051-7051. DOI: 10.1200/Jco.2007.25.18_Suppl.7051 |
0.458 |
|
| 2007 |
Gupta B, Sait SN, Block AW, Ford LA, Moysich KB, Baer MR. Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer Journal of Clinical Oncology. 25: 17506-17506. DOI: 10.1200/Jco.2007.25.18_Suppl.17506 |
0.405 |
|
| 2006 |
Jayaprakash V, Rigual NR, Moysich KB, Loree TR, Nasca MA, Menezes RJ, Reid ME. Chemoprevention of head and neck cancer with aspirin: a case-control study. Archives of Otolaryngology--Head & Neck Surgery. 132: 1231-6. PMID 17116820 DOI: 10.1001/Archotol.132.11.1231 |
0.487 |
|
| 2006 |
Beehler GP, Sekhon M, Baker JA, Teter BE, McCann SE, Rodabaugh KJ, Moysich KB. Risk of ovarian cancer associated with BMI varies by menopausal status. The Journal of Nutrition. 136: 2881-6. PMID 17056817 DOI: 10.1093/Jn/136.11.2881 |
0.492 |
|
| 2006 |
Weiss JR, Kopecky KJ, Godwin J, Anderson J, Willman CL, Moysich KB, Slovak ML, Hoque A, Ambrosone CB. Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials. Leukemia. 20: 2169-71. PMID 17008887 DOI: 10.1038/Sj.Leu.2404421 |
0.618 |
|
| 2006 |
Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. Bmc Cancer. 6: 203. PMID 16882345 DOI: 10.1186/1471-2407-6-203 |
0.65 |
|
| 2006 |
Li Y, Moysich KB, Baer MR, Weiss JR, Brasure J, Graham S, McCann SE. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leukemia Research. 30: 1507-15. PMID 16678899 DOI: 10.1016/J.Leukres.2006.03.017 |
0.674 |
|
| 2006 |
Baker JA, Odunuga OO, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB. Active and passive smoking and risk of ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 211-8. PMID 16515593 DOI: 10.1111/J.1525-1438.2006.00473.X |
0.452 |
|
| 2006 |
Menezes RJ, Swede H, Niles R, Moysich KB. Regular use of aspirin and prostate cancer risk (United States). Cancer Causes & Control : Ccc. 17: 251-6. PMID 16489532 DOI: 10.1007/S10552-005-0450-Z |
0.705 |
|
| 2006 |
Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB. Regular aspirin use and esophageal cancer risk. International Journal of Cancer. Journal International Du Cancer. 119: 202-7. PMID 16450404 DOI: 10.1002/Ijc.21814 |
0.49 |
|
| 2006 |
Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL. p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 80-5. PMID 16434591 DOI: 10.1158/1055-9965.Epi-05-0444 |
0.678 |
|
| 2006 |
Baker JA, Beehler GP, Sawant AC, Jayaprakash V, McCann SE, Moysich KB. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. The Journal of Nutrition. 136: 166-71. PMID 16365077 DOI: 10.1093/Jn/136.1.166 |
0.474 |
|
| 2006 |
Xie B, Freudenheim JL, Cummings SS, Singh B, He H, McCann SE, Moysich KB, Shields PG. Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer. Carcinogenesis. 27: 307-10. PMID 16113052 DOI: 10.1093/Carcin/Bgi215 |
0.426 |
|
| 2006 |
Weiss JR, Baker JA, Baer MR, Menezes RJ, Nowell S, Moysich KB. Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia. Leukemia Research. 30: 164-9. PMID 16099041 DOI: 10.1016/J.Leukres.2005.06.023 |
0.708 |
|
| 2006 |
Weiss JR, Baer MR, Ambrosone CB, Blanco JG, Hutson A, Ford LA, Moysich KB. High Concordance between Pharmacogenetic Analysis of Bone Marrow and Buccal Cell Samples in Acute Myeloid Leukemia. Blood. 108: 2364-2364. DOI: 10.1182/Blood.V108.11.2364.2364 |
0.664 |
|
| 2006 |
Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Graham S, Brasure JR, McCann SE. Diet and Endometrial Cancer: A Hospital-Based Case-Control Study American Journal of Epidemiology. 163: S115-S115. DOI: 10.1093/Aje/163.Suppl_11.S115-A |
0.369 |
|
| 2005 |
Moysich KB, Baker JA, Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2923-8. PMID 16365011 DOI: 10.1158/1055-9965.Epi-05-0457 |
0.465 |
|
| 2005 |
McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutrition and Cancer. 53: 33-41. PMID 16351504 DOI: 10.1207/S15327914Nc5301_4 |
0.409 |
|
| 2005 |
Varma G, Varma R, Huang H, Pryshchepava A, Groth J, Fleming D, Nowak NJ, McQuaid D, Conroy J, Mahoney M, Moysich K, Falkner KL, Geradts J. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. British Journal of Cancer. 93: 699-708. PMID 16222315 DOI: 10.1038/Sj.Bjc.6602784 |
0.392 |
|
| 2005 |
Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB. Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutrition and Cancer. 52: 15-21. PMID 16090999 DOI: 10.1207/S15327914Nc5201_2 |
0.463 |
|
| 2005 |
Baker JA, Weiss JR, Czuczman MS, Menezes RJ, Ambrosone CB, Moysich KB. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes & Control : Ccc. 16: 301-8. PMID 15947882 DOI: 10.1007/S10552-004-3074-9 |
0.694 |
|
| 2005 |
Baker JA, Buck GM, Vena JE, Moysich KB. Fertility patterns prior to testicular cancer diagnosis. Cancer Causes & Control : Ccc. 16: 295-9. PMID 15947881 DOI: 10.1007/S10552-004-4024-2 |
0.464 |
|
| 2005 |
Swede H, Mirand AL, Menezes RJ, Moysich KB. Association of regular aspirin use and breast cancer risk. Oncology. 68: 40-7. PMID 15802928 DOI: 10.1159/000084818 |
0.732 |
|
| 2005 |
Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 20-6. PMID 15668471 |
0.781 |
|
| 2004 |
Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutrition and Cancer. 50: 206-13. PMID 15623468 DOI: 10.1207/S15327914Nc5002_11 |
0.436 |
|
| 2004 |
Yang J, Tan D, Asch HL, Swede H, Bepler G, Geradts J, Moysich KB. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 46: 29-42. PMID 15364130 DOI: 10.1016/J.Lungcan.2004.03.022 |
0.668 |
|
| 2004 |
Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM, Moysich KB, McCarthy PL. Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. International Journal of Epidemiology. 33: 1025-33. PMID 15166190 DOI: 10.1093/Ije/Dyh201 |
0.393 |
|
| 2004 |
Freudenheim JL, Bonner M, Krishnan S, Ambrosone CB, Graham S, McCann SE, Moysich KB, Bowman E, Nemoto T, Shields PG. Diet and alcohol consumption in relation to p53 mutations in breast tumors. Carcinogenesis. 25: 931-9. PMID 14742318 DOI: 10.1093/Carcin/Bgh088 |
0.359 |
|
| 2004 |
Quirk JT, Natarajan N, Mettlin CJ, Moysich KB, Swede H. Risk factors for invasive epithelial ovarian cancer by histologic subtype Online Journal of Health and Allied Sciences. 3. |
0.71 |
|
| 2003 |
Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Research : Bcr. 5: R45-51. PMID 12631398 DOI: 10.1186/Bcr570 |
0.474 |
|
| 2003 |
Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Romero-Gutierrez M, Brooks JS, Michalek AM. Variation of the prognostic significance of HER-2 expression in breast cancer according to tumor size. The Breast Journal. 9: 98-105. PMID 12603382 DOI: 10.1046/J.1524-4741.2003.09207.X |
0.673 |
|
| 2002 |
Bonner MR, McCann SE, Moysich KB. Dietary factors and the risk of testicular cancer. Nutrition and Cancer. 44: 35-43. PMID 12672639 DOI: 10.1207/S15327914Nc441_5 |
0.455 |
|
| 2002 |
Moysich KB, Menezes RJ, Baker JA, Falkner KL. Environmental exposure to polychlorinated biphenyls and breast cancer risk. Reviews On Environmental Health. 17: 263-77. PMID 12611469 DOI: 10.1515/Reveh.2002.17.4.263 |
0.452 |
|
| 2002 |
Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen GM, Bepler G. Regular aspirin use and lung cancer risk. Bmc Cancer. 2: 31. PMID 12453317 DOI: 10.1186/1471-2407-2-31 |
0.718 |
|
| 2002 |
McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. The Journal of Nutrition. 132: 3036-41. PMID 12368392 DOI: 10.1093/Jn/131.10.3036 |
0.486 |
|
| 2002 |
Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Evaluation of β1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer American Journal of Obstetrics and Gynecology. 187: 575-580. PMID 12237630 DOI: 10.1067/Mob.2002.125888 |
0.335 |
|
| 2002 |
Menezes RJ, Huber KR, Mahoney MC, Moysich KB. Regular use of aspirin and pancreatic cancer risk. Bmc Public Health. 2: 18. PMID 12213184 DOI: 10.1186/1471-2458-2-18 |
0.514 |
|
| 2002 |
Moysich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. The Lancet. Oncology. 3: 269-79. PMID 12067803 DOI: 10.1016/S1470-2045(02)00727-1 |
0.417 |
|
| 2002 |
Thrasher JF, Cummings KM, Michalek AM, Mahoney MC, Moysich KB, Pillittere DM. Colorectal cancer screening among individuals with and without a family history. Journal of Public Health Management and Practice : Jphmp. 8: 1-9. PMID 11889847 DOI: 10.1097/00124784-200203000-00002 |
0.328 |
|
| 2002 |
Moysich KB, Ambrosone CB, Mendola P, Kostyniak PJ, Greizerstein HB, Vena JE, Menezes RJ, Swede H, Shields PG, Freudenheim JL. Exposures associated with serum organochlorine levels among postmenopausal women from western New York State. American Journal of Industrial Medicine. 41: 102-10. PMID 11813215 DOI: 10.1002/Ajim.10043 |
0.633 |
|
| 2001 |
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detection and Prevention. 25: 511-9. PMID 12132871 |
0.659 |
|
| 2001 |
McCann SE, Moysich KB, Mettlin C. Intakes of selected nutrients and food groups and risk of ovarian cancer Nutrition and Cancer. 39: 19-28. PMID 11588898 DOI: 10.1207/S15327914Nc391_3 |
0.468 |
|
| 2001 |
Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 10: 903-6. PMID 11489759 |
0.715 |
|
| 2001 |
Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, Moysich KB, Tessari JD, Wolff MS, Zheng T, Hunter DJ. 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies Journal of the National Cancer Institute. 93: 768-776. PMID 11353787 DOI: 10.1093/Jnci/93.10.768 |
0.488 |
|
| 2000 |
Moysich KB, Freudenheim JL, Baker JA, Ambrosone CB, Bowman ED, Schisterman EF, Vena JE, Shields PG. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk Molecular Carcinogenesis. 27: 2-9. PMID 10642431 DOI: 10.1002/(Sici)1098-2744(200001)27:1<2::Aid-Mc2>3.0.Co;2-W |
0.441 |
|
| 1999 |
Freudenheim JL, Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, Muti P, Laughlin R, Nemoto T, Harty LC, Adam Crits G, Chan AWK, Shields PG. Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk Cancer Causes and Control. 10: 369-377. PMID 10530606 DOI: 10.1023/A:1008950717205 |
0.401 |
|
| 1999 |
Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk Cancer Epidemiology Biomarkers and Prevention. 8: 41-44. PMID 9950238 |
0.398 |
|
| 1998 |
Mendola P, Moysich KB, Freudenheim JL, Shields PG, Schisterman EF, Graham S, Vena JE, Marshall JR, Ambrosone CB. Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1 Epidemiology. 9: 666-668. PMID 9799179 DOI: 10.1097/00001648-199811000-00018 |
0.301 |
|
| 1998 |
Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, Freudenheim JL. Environmental organochlorine exposure and postmenopausal breast cancer risk Cancer Epidemiology Biomarkers and Prevention. 7: 181-188. PMID 9521429 |
0.345 |
|
| 1998 |
Moysich KB, Shields PG, Freudenheim JL, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S. CYTOCHROME P4501A1 POLYMORPHISM, POLYCHLORINATED BIPHENYL (PCB) EXPOSURE AND POSTMENOPAUSAL BREAST CANCER RISK Epidemiology. 9: S153. DOI: 10.1097/00001648-199807001-00529 |
0.432 |
|
| 1997 |
Freudenheim JL, Marshall JR, Vena JE, Moysich KB, Muti P, Laughlin R, Nemoto T, Graham S. Lactation history and breast cancer risk American Journal of Epidemiology. 146: 932-938. PMID 9400334 DOI: 10.1093/Oxfordjournals.Aje.A009219 |
0.334 |
|
| Show low-probability matches. |